Study Summary
This trial is testing a new treatment for gastric cancer that has spread to the abdomen. The new treatment is a combination of two drugs, and this study will test how well it works.
- Peritoneal Carcinomatosis
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: 20 weeks
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
1 Treatment Group
Intraperitoneal docetaxel
1 of 1
Experimental Treatment
30 Total Participants · 1 Treatment Group
Primary Treatment: Intraperitoneal docetaxel · No Placebo Group · Phase 1
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
How many research participants are involved in this experiment?
"Affirmative. The information located on clinicaltrials.gov indicates that this research is presently searching for volunteers. This investigation was first posted to the website in November 1st 2020 and recently updated on November 7th 2022, with a goal of enlisting 30 patients from one single medical site." - Anonymous Online Contributor
Are there any other investigations that have employed Intraperitoneal docetaxel?
"Currently, 320 Intraperitoneal docetaxel trials are underway. 126 of them have reached the third phase of research and development. Most of these experiments originate in Fuzhou, Fujian; however, there are 22389 participating sites for this procedure worldwide." - Anonymous Online Contributor
What are the known risks of administering Intraperitoneal docetaxel to patients?
"Our experts at Power assigned an approximate safety rating of 1 to intraperitoneal docetaxel, as this is only a Phase 1 trial and there is limited data available on its efficacy or risk profile." - Anonymous Online Contributor
Are any fresh participants being admitted to this trial?
"Clinicaltrials.gov confirms that this medical trial was first made public on November 1st 2020 and is currently recruiting participants. The listing of the study has been updated as recently as November 7th 2021." - Anonymous Online Contributor
What health issues is Intraperitoneal docetaxel commonly administered for?
"Intraperitoneal docetaxel is a widely used medication for the treatment of malignant cancerous growths. It can also be deployed to treat more specific conditions such as esophageal neoplasms, sarcoma, and advanced directives." - Anonymous Online Contributor